Public Employees Retirement System of Ohio Makes New $2 Million Investment in Bruker Corporation $BRKR

Key Points

• Ohio’s public employees’ retirement system purchased 33,220 Bruker shares worth approximately $2 million in the second quarter. Institutional investors collectively own 79.52% of the company.
• Analysts have mixed views on Bruker, with a consensus rating of “Hold” and an average price target of $56.64, despite some firms raising targets as high as $70.
• Bruker reported quarterly EPS of $0.49, beating estimates of $0.38, while revenue rose 5.2% year over year to $838.5 million. The company also declared a quarterly dividend of $0.05 per share, representing a 0.3% annualized yield.

Public Employees Retirement System of Ohio bought a new stake in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 33,220 shares of the medical research company's stock, valued at approximately $1,999,000.

Several other institutional investors also recently modified their holdings of BRKR. Los Angeles Capital Management LLC bought a new position in Bruker in the fourth quarter valued at approximately $26,000. Allworth Financial LP raised its position in shares of Bruker by 40.6% during the 3rd quarter. Allworth Financial LP now owns 890 shares of the medical research company's stock valued at $29,000 after acquiring an additional 257 shares during the last quarter. Essential Partners LLC acquired a new position in shares of Bruker in the 1st quarter valued at $36,000. Global Retirement Partners LLC acquired a new position in shares of Bruker in the 2nd quarter valued at $38,000. Finally, Parallel Advisors LLC boosted its position in shares of Bruker by 121.0% in the 4th quarter. Parallel Advisors LLC now owns 875 shares of the medical research company's stock worth $41,000 after purchasing an additional 479 shares during the last quarter. Institutional investors and hedge funds own 79.52% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on BRKR shares. Wolfe Research assumed coverage on Bruker in a research note on Monday, June 1st. They issued a "peer perform" rating on the stock. Zacks Research lowered Bruker from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, September 2nd. JPMorgan Chase & Co. upped their price target on Bruker from $55.00 to $65.00 and gave the company an "overweight" rating in a research note on Monday, June 8th. UBS Group set a $60.00 price target on shares of Bruker in a research report on Wednesday, June 24th. Finally, Leerink Partners lifted their price objective on shares of Bruker from $60.00 to $70.00 and gave the stock an "outperform" rating in a research note on Tuesday, July 7th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Bruker presently has a consensus rating of "Hold" and an average target price of $56.64.

Bruker Stock Performance

Shares of BRKR stock opened at $58.50 on Monday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.92 and a current ratio of 1.85. Bruker Corporation has a 52 week low of $29.84 and a 52 week high of $65.30. The company's 50 day moving average price is $58.76 and its two-hundred day moving average price is $48.73. The company has a market capitalization of $8.91 billion, a P/E ratio of -83.57, a price-to-earnings-growth ratio of 1.79 and a beta of 1.26.

Bruker (NASDAQ:BRKR - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The medical research company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.11. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. The company had revenue of $838.50 million during the quarter, compared to the consensus estimate of $853.57 million. During the same quarter in the prior year, the firm earned $0.32 earnings per share. The firm's revenue was up 5.2% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. On average, analysts expect that Bruker Corporation will post 2.12 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 7th. Shareholders of record on Monday, September 21st will be paid a $0.05 dividend. The ex-dividend date of this dividend is Monday, September 21st. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. Bruker's dividend payout ratio (DPR) is currently -28.57%.

Bruker Company Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker's product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.